SCHOTT Pharma AG & Co. KGaA (1SXP) — Net Asset Momentum
SCHOTT Pharma AG & Co. KGaA (1SXP) recorded a net asset momentum of 14.5% as of June 2024, with net assets of €792.27 Million EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See how many days can SCHOTT Pharma AG & Co. KGaA fund operations to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
SCHOTT Pharma AG & Co. KGaA Net Asset Momentum (2020–2024)
This chart tracks SCHOTT Pharma AG & Co. KGaA's year-over-year net asset growth across 5 annual reporting periods from 2020 to 2024. The most recent momentum reading is +14.5%, with net assets of €792.27 Million EUR as of June 2024. Read SCHOTT Pharma AG & Co. KGaA total liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for SCHOTT Pharma AG & Co. KGaA (2020–2024)
The table below shows the complete annual net asset history for SCHOTT Pharma AG & Co. KGaA from 2020 to 2024, covering 5 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see 1SXP market cap overview.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | €792.27 Million | €1.44 Billion | €650.00 Million | ▲ +14.5% |
| 2023 | €692.18 Million | €1.23 Billion | €539.65 Million | ▼ -2.4% |
| 2022 | €709.04 Million | €1.20 Billion | €487.46 Million | ▲ +69.1% |
| 2021 | €419.42 Million | €739.89 Million | €320.48 Million | ▲ +32.9% |
| 2020 | €315.66 Million | €596.02 Million | €280.36 Million | — |